Evidence map›Paper›PMID 33004045›Full record

Observational studyCardiovascular diabetology2020

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).

Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, Carmen Mignogna, Gaetano Leto, Giuseppe Pascarella, Ivano Mezzaroma, Miriam Lichtner, Paolo Pozzilli, Felice Eugenio Agrò and 7 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Cardiovascular diabetology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The association between sleep characteristics and the risk of all-cause mortality among individuals with cardiometabolic multimorbidity: a prospective study of UK Biobank.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19-related deaths among people with multimorbidity: a cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ernesto MaddaloniUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Luca D'OnofrioUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Francesco AlessandriUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Carmen MignognaUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Gaetano LetoSanta Maria Goretti Hospital, Polo Pontino Sapienza University, Latina, Italy.
Giuseppe PascarellaCampus Bio-Medico University of Rome, Rome, Italy.
Ivano MezzaromaUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Miriam LichtnerSanta Maria Goretti Hospital, Polo Pontino Sapienza University, Latina, Italy.
Paolo PozzilliCampus Bio-Medico University of Rome, Rome, Italy.
Felice Eugenio AgròCampus Bio-Medico University of Rome, Rome, Italy.
Monica RoccoSant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
Francesco PuglieseUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Andrea LenziUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Rury R HolmanDiabetes Trial Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Claudio Maria MastroianniUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Raffaella BuzzettiUmberto I "Policlinico" General Hospital, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. Raffaella.buzzetti@uniroma1.it.ORCID 0000-0003-1490-6041
CoViDiab Study Group

Funding

European Foundation for the Study of Diabetes MS 2017_2
6 · The paper itself

Abstract

backgroundCardiometabolic disorders may worsen Covid-19 outcomes. We investigated features and Covid-19 outcomes for patients with or without diabetes, and with or without cardiometabolic multimorbidity.

methodsWe collected and compared data retrospectively from patients hospitalized for Covid-19 with and without diabetes, and with and without cardiometabolic multimorbidity (defined as ≥ two of three risk factors of diabetes, hypertension or dyslipidaemia). Multivariate logistic regression was used to assess the risk of the primary composite outcome (any of mechanical ventilation, admission to an intensive care unit [ICU] or death) in patients with diabetes and in those with cardiometabolic multimorbidity, adjusting for confounders.

resultsOf 354 patients enrolled, those with diabetes (n = 81), compared with those without diabetes (n = 273), had characteristics associated with the primary composite outcome that included older age, higher prevalence of hypertension and chronic obstructive pulmonary disease (COPD), higher levels of inflammatory markers and a lower PaO2/FIO2 ratio. The risk of the primary composite outcome in the 277 patients who completed the study as of May 15

conclusionsPatients with diabetes hospitalized for Covid-19 present with high-risk features. They are at increased risk of adverse outcomes, likely because diabetes clusters with other cardiometabolic conditions.

Indexed as

BetacoronavirusAgedAged, 80 and overCardiovascular DiseasesCoronavirus InfectionsCOVID-19Diabetes MellitusFemaleFollow-Up StudiesHumansMaleMetabolic DiseasesMiddle AgedMultimorbidityPandemicsPneumonia, ViralCOPDCovid-19DiabetesHypertensionSARS-CoV-2

Identifiers

PMID33004045
PMCPMC7528157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.